{"id":"https://openalex.org/W2140618548","doi":"https://doi.org/10.1093/annonc/mdj101","title":"An economic evaluation of Herceptin\u00ae in adjuvant setting: the Breast Cancer International Research Group 006 trial","display_name":"An economic evaluation of Herceptin\u00ae in adjuvant setting: the Breast Cancer International Research Group 006 trial","publication_year":2005,"publication_date":"2005-11-30","ids":{"openalex":"https://openalex.org/W2140618548","doi":"https://doi.org/10.1093/annonc/mdj101","mag":"2140618548","pmid":"https://pubmed.ncbi.nlm.nih.gov/16319089"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdj101","doi":"https://doi.org/10.1093/annonc/mdj101","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdj101","pdf_url":"http://www.annalsofoncology.org/article/S0923753419435321/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.annalsofoncology.org/article/S0923753419435321/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034807071","display_name":"Mattias Neyt","orcid":"https://orcid.org/0000-0002-9593-3887","observed_orcids":["https://orcid.org/0000-0002-9593-3887"]},"institutions":[{"id":"https://openalex.org/I32597200","display_name":"Ghent University","ror":"https://ror.org/00cv9y106","country_code":"BE","type":"education","lineage":["https://openalex.org/I32597200"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"M. Neyt","raw_affiliation_strings":["Faculty of Economics and Business Administration, Department of Economics, Ghent University, Ghent. mattias.neyt@ugent.be","Faculty of Economics and Business Administration, Department of Economics, Ghent University, Ghent"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Economics and Business Administration, Department of Economics, Ghent University, Ghent. mattias.neyt@ugent.be","institution_ids":["https://openalex.org/I32597200"]},{"raw_affiliation_string":"Faculty of Economics and Business Administration, Department of Economics, Ghent University, Ghent","institution_ids":["https://openalex.org/I32597200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027021512","display_name":"Johan Albrecht","orcid":"https://orcid.org/0000-0003-2485-4062","observed_orcids":["https://orcid.org/0000-0003-2485-4062"]},"institutions":[{"id":"https://openalex.org/I32597200","display_name":"Ghent University","ror":"https://ror.org/00cv9y106","country_code":"BE","type":"education","lineage":["https://openalex.org/I32597200"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"J. Albrecht","raw_affiliation_strings":["Faculty of Economics and Business Administration, Department of Economics, Ghent University, Ghent"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Economics and Business Administration, Department of Economics, Ghent University, Ghent","institution_ids":["https://openalex.org/I32597200"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110478329","display_name":"V.F.J. Cocquyt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801227569","display_name":"Ghent University Hospital","ror":"https://ror.org/00xmkp704","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801227569"]},{"id":"https://openalex.org/I32597200","display_name":"Ghent University","ror":"https://ror.org/00cv9y106","country_code":"BE","type":"education","lineage":["https://openalex.org/I32597200"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"V. Cocquyt","raw_affiliation_strings":["Faculty of Medicine and Health Sciences, Department of Medical Oncology, University Hospital Ghent, Ghent, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine and Health Sciences, Department of Medical Oncology, University Hospital Ghent, Ghent, Belgium","institution_ids":["https://openalex.org/I2801227569","https://openalex.org/I32597200"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5034807071"],"corresponding_institution_ids":["https://openalex.org/I32597200"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":19.7783,"has_fulltext":true,"cited_by_count":51,"citation_normalized_percentile":{"value":0.99116584,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"17","issue":"3","first_page":"381","last_page":"390"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7409999966621399},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cost-analysis","display_name":"cost analysis","score":0.5009999871253967},{"id":"https://openalex.org/keywords/microcosting","display_name":"micro-costing","score":0.7129999995231628},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.7670000195503235},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9070000052452087},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.7630000114440918},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.8339999914169312},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.7860000133514404},{"id":"https://openalex.org/keywords/reimbursement-policy","display_name":"reimbursement policy","score":0.6290000081062317},{"id":"https://openalex.org/keywords/value-for-money","display_name":"value for money","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9075115919113159},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8918986320495605},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8015013337135315},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6450825929641724},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6134658455848694},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5627371668815613},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.5270904302597046},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5003559589385986},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.427801251411438},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4245741367340088},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4195703864097595},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3388635814189911},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.29429084062576294},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18513309955596924},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.10195299983024597},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/annonc/mdj101","doi":"https://doi.org/10.1093/annonc/mdj101","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdj101","pdf_url":"http://www.annalsofoncology.org/article/S0923753419435321/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},{"id":"pmid:16319089","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16319089","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of oncology : official journal of the European Society for Medical Oncology","raw_type":"Journal Article"},{"id":"pmh:oai:archive.ugent.be:334437","doi":null,"is_oa":false,"landing_page_url":"https://biblio.ugent.be/publication/334437","pdf_url":null,"source":{"id":"https://openalex.org/S4306400478","display_name":"Ghent University Academic Bibliography (Ghent University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32597200","host_organization_name":"Ghent University","host_organization_lineage":["https://openalex.org/I32597200"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 0923-7534","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:open-archive.highwire.org:annonc:mdj101v1","doi":null,"is_oa":false,"landing_page_url":"http://annonc.oxfordjournals.org/cgi/content/short/mdj101v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdj101","doi":"https://doi.org/10.1093/annonc/mdj101","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdj101","pdf_url":"http://www.annalsofoncology.org/article/S0923753419435321/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308982","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421"},{"id":"https://openalex.org/F4320321910","display_name":"Universitair Ziekenhuis Gent","ror":"https://ror.org/00xmkp704"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2140618548.pdf","grobid_xml":"https://content.openalex.org/works/W2140618548.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W272932","https://openalex.org/W55079782","https://openalex.org/W275107321","https://openalex.org/W394121138","https://openalex.org/W1571272128","https://openalex.org/W1839333839","https://openalex.org/W1848530042","https://openalex.org/W1867197625","https://openalex.org/W1909697168","https://openalex.org/W1924784781","https://openalex.org/W1934173384","https://openalex.org/W2011000634","https://openalex.org/W2015410427","https://openalex.org/W2019273574","https://openalex.org/W2021326753","https://openalex.org/W2023338191","https://openalex.org/W2029542561","https://openalex.org/W2034440069","https://openalex.org/W2043951092","https://openalex.org/W2048686497","https://openalex.org/W2056182801","https://openalex.org/W2058522744","https://openalex.org/W2077759236","https://openalex.org/W2082802659","https://openalex.org/W2085772474","https://openalex.org/W2088666021","https://openalex.org/W2089190823","https://openalex.org/W2092591992","https://openalex.org/W2095156669","https://openalex.org/W2100375606","https://openalex.org/W2105189307","https://openalex.org/W2110442763","https://openalex.org/W2113411375","https://openalex.org/W2115759102","https://openalex.org/W2121271793","https://openalex.org/W2126620646","https://openalex.org/W2140780929","https://openalex.org/W2141165376","https://openalex.org/W2141393790","https://openalex.org/W2146384083","https://openalex.org/W2149908785","https://openalex.org/W2152848170","https://openalex.org/W2159459001","https://openalex.org/W2163640332","https://openalex.org/W2165528796","https://openalex.org/W2168631900","https://openalex.org/W2170369073","https://openalex.org/W2318605753","https://openalex.org/W6684052341"],"related_works":["https://openalex.org/W2734040110","https://openalex.org/W2019707316","https://openalex.org/W1972180671","https://openalex.org/W2100717480","https://openalex.org/W2101998240","https://openalex.org/W2059170159","https://openalex.org/W2101341097","https://openalex.org/W2037906500","https://openalex.org/W1985914856","https://openalex.org/W1978906303"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}